(VIANEWS) – Today, the AICapitalize artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Flex FLEX, MarketAxess Holdings MKTX and others.
Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.
AICapitalize provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.
AICapitalize officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.
In the next session, Via News will report the finding on the algorithm precision.
| Financial Asset | Accuracy | Close Price | Prediction |
|---|---|---|---|
| Flex (FLEX) | 99.52% | $30.4 | ⇧ $30.99 |
| MarketAxess Holdings (MKTX) | 94.18% | $291.02 | ⇧ $298.36 |
| Marriott International (MAR) | 94.06% | $224.96 | ⇧ $228.13 |
| Dropbox (DBX) | 93.8% | $29.53 | ⇧ $29.89 |
| Ross Stores (ROST) | 93.79% | $138.1 | ⇧ $140.01 |
| CoStar Group (CSGP) | 93.48% | $87.16 | ⇧ $89.06 |
| Cisco (CSCO) | 93.37% | $50.27 | ⇧ $51.44 |
| Credit Acceptance Corporation (CACC) | 93.25% | $529.69 | ⇧ $544.13 |
| Amicus Therapeutics (FOLD) | 93.15% | $14.32 | ⇧ $14.6 |
| Intuitive Surgical (ISRG) | 93.05% | $337.46 | ⇧ $346.49 |
| CDW Corporation (CDW) | 89.34% | $226.89 | ⇧ $231.06 |
| SPS Commerce (SPSC) | 89.31% | $193.92 | ⇧ $197.05 |
| Analog Devices (ADI) | 89.04% | $198.51 | ⇧ $200.73 |
| NVIDIA (NVDA) | 88.94% | $490.76 | ⇧ $499.89 |
| Insulet (PODD) | 88.71% | $216.26 | ⇧ $221.27 |
| Biogen (BIIB) | 88.4% | $257.67 | ⇧ $264.98 |
| Alnylam Pharmaceuticals (ALNY) | 88.29% | $193.02 | ⇧ $197.54 |
| Align Technology (ALGN) | 87.91% | $274.47 | ⇧ $282.99 |
| Pepsico (PEP) | 87.67% | $169.28 | ⇧ $175.33 |
| Exact Sciences (EXAS) | 83.93% | $74.15 | ⇧ $75.1 |
| Monolithic Power Systems (MPWR) | 83.91% | $626.31 | ⇧ $645.14 |
| Cognizant Technology Solutions (CTSH) | 83.73% | $75.17 | ⇧ $76.94 |
| Amgen (AMGN) | 83.61% | $287.07 | ⇧ $290.71 |
| Adobe (ADBE) | 83.61% | $594.01 | ⇧ $604.28 |
| Wix.com (WIX) | 83.59% | $123.25 | ⇧ $123.46 |
| Microsoft (MSFT) | 83.57% | $374.36 | ⇧ $385.72 |
| Freshpet (FRPT) | 83.51% | $86.79 | ⇧ $88.76 |
| IDEXX Laboratories (IDXX) | 83.5% | $554.12 | ⇧ $565.02 |
| Gilead Sciences (GILD) | 83.45% | $80.9 | ⇧ $82.99 |
| American Airlines (AAL) | 83.38% | $13.72 | ⇩ $13.15 |
1. Flex (FLEX)
Shares of Flex jumped by a staggering 18.75% in from $25.6 to $30.40 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Flex Ltd. provides technology, supply chain, and manufacturing solutions in Asia, the Americas, and Europe. It operates through three segments: Flex Agility Solutions (FAS), Flex Reliability Solutions (FRS), and Nextracker. The FAS segment offers flexible supply and manufacturing system comprising communications, enterprise and cloud solution, which includes data, edge, and communications infrastructure; lifestyle solution including appliances, consumer packaging, floorcare, micro mobility, and audio; and consumer devices, such as mobile and high velocity consumer devices. Its FRS segment provides complex ramps with specialized production models and critical environments, which comprise automotive including next generation mobility, autonomous, connectivity, electrification, and smart technologies; health solutions, such as medical devices, medical equipment, and drug delivery; and industrial solutions including capital equipment, industrial devices, and renewables and grid edge. The Nextracker segment offers solar tracker and software solutions, which are used in utility-scale and ground-mounted distributed generation solar projects. In addition, it provides a broad array of services including design and engineering, component services, rapid prototyping, fulfillment, and circular economy solutions. The company was formerly known as Flextronics International Ltd. and changed its name to Flex Ltd. in September 2016. Flex Ltd. was founded in 1969 and is headquartered in Singapore.
Sales Growth
Flex’s sales growth is negative 13.2% for the ongoing quarter and negative 7.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 30.04B for the twelve trailing months.
More news about Flex.
2. MarketAxess Holdings (MKTX)
Shares of MarketAxess Holdings rose by a staggering 22.43% in from $237.7 to $291.02 at 18:21 EST on Friday, after five successive sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
MarketAxess Holdings Inc., together with its subsidiaries, operates an electronic trading platform for institutional investor and broker-dealer companies worldwide. It offers the access to liquidity in the U.S. investment-grade bonds, U.S. high-yield bonds, and U.S. Treasuries, as well as municipal bonds, emerging market debts, Eurobonds, and other fixed-income securities. The company, through its Open Trading protocols, executes bond trades between and among institutional investor and broker-dealer clients in an all-to-all anonymous trading environment for corporate bonds. It also offers trading-related products and services, including composite+ pricing and other market data products to assist clients with trading decisions; auto-execution and other execution services for clients requiring specialized workflow solutions; connectivity solutions that facilitate straight-through processing; and technology services to optimize trading environments. In addition, the company provides various pre-and post-trade services, such as trade matching, trade publication, regulatory transaction reporting, and market and reference data across a range of fixed-income and other products. MarketAxess Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.
More news about MarketAxess Holdings.
3. Marriott International (MAR)
Shares of Marriott International jumped by a staggering 11.34% in from $202.05 to $224.96 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide. The company operates through U.S. and Canada, and International segments. It operates its properties under the JW Marriott, The Ritz-Carlton, Ritz-Carlton Reserve, W Hotels, The Luxury Collection, St. Regis, EDITION, Bvlgari, Renaissance, Le Méridien, Marriott, Sheraton, Westin, Four Points, Delta Hotels by Marriott, Autograph Collection, Tribute Portfolio, Marriott Hotels, Marriott Executive Apartments, Marriott Vacation Club, Gaylord Hotels, Design Hotels, Courtyard, Residence Inn, Fairfield, SpringHill Suites, TownePlace Suites, Protea Hotels, Aloft Hotels, AC Hotels by Marriott, Element Hotels, and Moxy Hotels brand names. It operates properties under 30 brand names in 138 countries and territories. Marriott International, Inc. was founded in 1927 and is headquartered in Bethesda, Maryland.
More news about Marriott International.
4. Dropbox (DBX)
Shares of Dropbox jumped 5.46% in from $28 to $29.53 at 18:21 EST on Friday, after two successive sessions in a row of losses. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Dropbox, Inc. provides a content collaboration platform worldwide. The company's platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
Moving Average
Dropbox’s value is above its 50-day moving average of $27.64 and way higher than its 200-day moving average of $25.44.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 2.47B for the twelve trailing months.
Yearly Top and Bottom Value
Dropbox’s stock is valued at $29.53 at 18:21 EST, under its 52-week high of $30.50 and way higher than its 52-week low of $18.71.
Volatility
Dropbox’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.15%, a positive 0.36%, and a positive 1.16%.
Dropbox’s highest amplitude of average volatility was 1.11% (last week), 1.12% (last month), and 1.16% (last quarter).
More news about Dropbox.
5. Ross Stores (ROST)
Shares of Ross Stores rose 6.64% in from $129.5 to $138.10 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names in the United States. Its stores primarily offer apparel, accessories, footwear, and home fashions. The company's Ross Dress for Less stores sell its products at department and specialty stores primarily to middle income households; and dd's DISCOUNTS stores sell its products at department and discount stores for households with moderate income. Ross Stores, Inc. was incorporated in 1957 and is headquartered in Dublin, California.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 19.57B for the twelve trailing months.
Volatility
Ross Stores’s last week, last month’s, and last quarter’s current intraday variation average was 0.37%, 0.33%, and 1.04%.
Ross Stores’s highest amplitude of average volatility was 0.37% (last week), 0.82% (last month), and 1.04% (last quarter).
Sales Growth
Ross Stores’s sales growth for the current quarter is 10.2%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ross Stores’s stock is considered to be oversold (<=20).
More news about Ross Stores.
6. CoStar Group (CSGP)
Shares of CoStar Group rose 5.43% in from $82.67 to $87.16 at 18:21 EST on Friday, after five sequential sessions in a row of gains. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. The company offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar Sales, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. It also provides Leasing, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. The company was founded in 1987 and is headquartered in Washington, the District of Columbia.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 2.39B for the twelve trailing months.
More news about CoStar Group.
7. Cisco (CSCO)
Shares of Cisco rose 4.4% in from $48.15 to $50.27 at 18:21 EST on Friday, after four sequential sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company also offers switching portfolio encompasses campus switching as well as data center switching; enterprise routing portfolio interconnects public and private wireline and mobile networks, delivering highly secure, and reliable connectivity to campus, data center and branch networks; wireless products include wireless access points and controllers; and compute portfolio including the cisco unified computing system, hyperflex, and software management capabilities, which combine computing, networking, and storage infrastructure management and virtualization. In addition, it provides Internet for the future product consists of routed optical networking, 5G, silicon, and optics solutions; collaboration products, such as meetings, collaboration devices, calling, contact center, and communication platform as a service; end-to-end security product consists of network security, cloud security, security endpoints, unified threat management, and zero trust; and optimized application experiences products including full stack observability and network assurance. Further, the company offers a range of service and support options for its customers, including technical support and advanced services and advisory services. It serves businesses of various sizes, public institutions, governments, and service providers. The company sells its products and services directly, as well as through systems integrators, service providers, other resellers, and distributors. Cisco Systems, Inc. has strategic alliances with other companies. Cisco Systems, Inc. was incorporated in 1984 and is headquartered in San Jose, California.
More news about Cisco.
8. Credit Acceptance Corporation (CACC)
Shares of Credit Acceptance Corporation rose by a staggering 16.08% in from $456.31 to $529.69 at 18:21 EST on Friday, after two successive sessions in a row of losses. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Credit Acceptance Corporation engages in the provision of financing programs, and related products and services to independent and franchised automobile dealers in the United States. The company advances money to automobile dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps the amount collected from the consumers. It is also involved in the business of reinsuring coverage under vehicle service contracts sold to consumers by dealers on vehicles financed by the company. The company was incorporated in 1972 and is headquartered in Southfield, Michigan.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 929.4M for the twelve trailing months.
Moving Average
Credit Acceptance Corporation’s worth is way above its 50-day moving average of $445.24 and way above its 200-day moving average of $468.39.
More news about Credit Acceptance Corporation.
9. Amicus Therapeutics (FOLD)
Shares of Amicus Therapeutics jumped by a staggering 32.1% in from $10.84 to $14.32 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 68.4% and 72.2%, respectively.
Sales Growth
Amicus Therapeutics’s sales growth is 29.2% for the current quarter and 35.8% for the next.
More news about Amicus Therapeutics.
10. Intuitive Surgical (ISRG)
Shares of Intuitive Surgical rose 9.26% in from $308.86 to $337.46 at 18:21 EST on Friday, after five successive sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Yearly Top and Bottom Value
Intuitive Surgical’s stock is valued at $337.46 at 18:21 EST, under its 52-week high of $358.07 and way above its 52-week low of $222.65.
Sales Growth
Intuitive Surgical’s sales growth is 13.1% for the ongoing quarter and 18.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 19.5% and 19.5%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Intuitive Surgical’s stock is considered to be oversold (<=20).
More news about Intuitive Surgical.
11. CDW Corporation (CDW)
Shares of CDW Corporation jumped 7.65% in from $210.77 to $226.89 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
CDW Corporation provides information technology (IT) solutions in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products and services, as well as integrated IT solutions, including on-premise, hybrid, and cloud capabilities across hybrid infrastructure, digital experience, and security. Its hardware products comprise notebooks/mobile devices, network communications, desktop computers, video monitors, enterprise and data storage, and others; and software products consists of application suites, security, virtualization, operating systems, and network management. The company also provides advisory and design, software development, implementation, managed, professional, configuration, partner, and telecom services, as well as warranties; delivers and manages mission critical software, systems, and network solutions; and implementation and installation, and repair services to its customers through various third-party service providers. It serves government, education, and healthcare customers; and small, medium, and large business customers. CDW Corporation was founded in 1984 and is headquartered in Vernon Hills, Illinois.
Sales Growth
CDW Corporation’s sales growth is negative 2% for the present quarter and 3.2% for the next.
Moving Average
CDW Corporation’s worth is above its 50-day moving average of $211.55 and way higher than its 200-day moving average of $194.39.
More news about CDW Corporation.
12. SPS Commerce (SPSC)
Shares of SPS Commerce rose by a staggering 13.95% in from $170.18 to $193.92 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
SPS Commerce, Inc. provides cloud-based supply chain management solutions worldwide. It offers solutions through the SPS Commerce, a cloud-based platform that enhances the way retailers, suppliers, grocers, distributors, and logistics firms manage and fulfill omnichannel orders, optimize sell-through performance, and automate new trading relationships. The company also provides Fulfillment solution, an electronic data interchange solution that scales as a business grows, where companies use a single system to manage orders and logistics from various sales channels, including wholesale, eCommerce, and marketplaces; and Analytics product that enables organizations to enhance visibility into how products are selling through a single connection across various sales channels, including wholesale, eCommerce, and marketplaces, as well as enhances access and usage of sales and inventory data through a combination of analytics applications, network of connections, and industry-leading expertise. In addition, it offers various complimentary products, such as assortment product, which simplifies the communication of robust, accurate item data by automatically translating item attributes, and hierarchies; and community product that allows organizations to accelerate digitization of their supply chain and improve collaboration with suppliers through change management and onboarding programs. The company was formerly known as St. Paul Software, Inc. and changed its name to SPS Commerce, Inc. in May 2001. SPS Commerce, Inc. was incorporated in 1987 and is headquartered in Minneapolis, Minnesota.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 9.5% and 10.4%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 513.96M for the twelve trailing months.
More news about SPS Commerce.
13. Analog Devices (ADI)
Shares of Analog Devices rose 9.21% in from $181.77 to $198.51 at 18:21 EST on Friday, after five sequential sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems products in the United States, rest of North and South America, Europe, Japan, China, and rest of Asia. The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and consumer markets; and power ICs that include performance, integration, and software design simulation tools for accurate power supply designs. It also offers amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and micro-electro-mechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, the company provides digital signal processing and system products for numeric calculations. It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, defense and healthcare, and communications markets through a direct sales force, third-party distributors, and independent sales representatives, as well as online. Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.
Yearly Top and Bottom Value
Analog Devices’s stock is valued at $198.51 at 18:21 EST, below its 52-week high of $202.77 and way above its 52-week low of $154.99.
Volatility
Analog Devices’s last week, last month’s, and last quarter’s current intraday variation average was 0.57%, 0.46%, and 1.19%.
Analog Devices’s highest amplitude of average volatility was 0.57% (last week), 1.18% (last month), and 1.19% (last quarter).
Moving Average
Analog Devices’s worth is way above its 50-day moving average of $177.77 and above its 200-day moving average of $182.73.
More news about Analog Devices.
14. NVIDIA (NVDA)
Shares of NVIDIA rose 5.02% in from $467.3 to $490.76 at 18:21 EST on Friday, after three sequential sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
NVIDIA Corporation provides graphics, and compute and networking solutions in the United States, Taiwan, China, and internationally. The company's Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building 3D designs and virtual worlds. Its Compute & Networking segment provides Data Center platforms and systems for AI, HPC, and accelerated computing; Mellanox networking and interconnect solutions; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; cryptocurrency mining processors; Jetson for robotics and other embedded platforms; and NVIDIA AI Enterprise and other software. The company's products are used in gaming, professional visualization, datacenter, and automotive markets. NVIDIA Corporation sells its products to original equipment manufacturers, original device manufacturers, system builders, add-in board manufacturers, retailers/distributors, independent software vendors, Internet and cloud service providers, automotive manufacturers and tier-1 automotive suppliers, mapping companies, start-ups, and other ecosystem participants. It has a strategic collaboration with Kroger Co. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.
Yearly Top and Bottom Value
NVIDIA’s stock is valued at $490.76 at 18:21 EST, below its 52-week high of $505.48 and way above its 52-week low of $138.84.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 410.2% and 380.6%, respectively.
More news about NVIDIA.
15. Insulet (PODD)
Shares of Insulet rose by a staggering 14.56% in from $188.77 to $216.26 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Volatility
Insulet’s last week, last month’s, and last quarter’s current intraday variation average was 1.21%, 0.85%, and 2.40%.
Insulet’s highest amplitude of average volatility was 1.21% (last week), 1.58% (last month), and 2.40% (last quarter).
Moving Average
Insulet’s worth is way above its 50-day moving average of $172.20 and below its 200-day moving average of $239.24.
Sales Growth
Insulet’s sales growth is 24.6% for the ongoing quarter and 23.6% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 27%, now sitting on 1.56B for the twelve trailing months.
Previous days news about Insulet
- Bull of the day: insulet (podd). According to Zacks on Thursday, 28 December, "I’m talking about Zacks Rank #1 (Strong Buy) Insulet ((PODD Quick QuotePODD – Free Report) ).", "Over the course of the last year, Insulet has beat earnings by an average of 23 cents, more than doubling expectations on average."
More news about Insulet.
16. Biogen (BIIB)
Shares of Biogen jumped by a staggering 10.61% in from $232.95 to $257.67 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Moving Average
Biogen’s value is above its 50-day moving average of $241.83 and below its 200-day moving average of $270.08.
Previous days news about Biogen
- Biogen inc. (biib) stock declines while market improves: some information for investors. According to Zacks on Thursday, 28 December, "In the latest trading session, Biogen Inc. (BIIB Quick QuoteBIIB – Free Report) closed at $260.58, marking a -0.52% move from the previous day. ", "Analysts and investors alike will be keeping a close eye on the performance of Biogen Inc. in its upcoming earnings disclosure. "
More news about Biogen.
17. Alnylam Pharmaceuticals (ALNY)
Shares of Alnylam Pharmaceuticals jumped by a staggering 14.58% in from $168.46 to $193.02 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Yearly Top and Bottom Value
Alnylam Pharmaceuticals’s stock is valued at $193.02 at 18:21 EST, way below its 52-week high of $242.39 and way higher than its 52-week low of $148.10.
Moving Average
Alnylam Pharmaceuticals’s worth is way higher than its 50-day moving average of $168.18 and above its 200-day moving average of $186.62.
Sales Growth
Alnylam Pharmaceuticals’s sales growth is 30.5% for the current quarter and 22.9% for the next.
More news about Alnylam Pharmaceuticals.
18. Align Technology (ALGN)
Shares of Align Technology rose by a staggering 28.2% in from $214.1 to $274.47 at 18:21 EST on Friday, after three consecutive sessions in a row of gains. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Volatility
Align Technology’s last week, last month’s, and last quarter’s current intraday variation average was 0.63%, 1.31%, and 2.46%.
Align Technology’s highest amplitude of average volatility was 0.63% (last week), 2.31% (last month), and 2.46% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 24.9% and 13.2%, respectively.
Yearly Top and Bottom Value
Align Technology’s stock is valued at $274.47 at 18:21 EST, way below its 52-week high of $413.20 and way above its 52-week low of $176.34.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 3.81B for the twelve trailing months.
More news about Align Technology.
19. Pepsico (PEP)
Shares of Pepsico rose 1.62% in from $166.58 to $169.28 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. The company offers its products primarily under the Lay's, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, Aquafina, Emperador, Diet Mountain Dew, Diet Pepsi, Gatorade Zero, Propel, Marias Gamesa, Ruffles, Sabritas, Saladitas, Tostitos, 7UP, Diet 7UP, H2oh!, Manzanita Sol, Mirinda, Pepsi Black, San Carlos, Toddy, Walkers, Chipsy, Kurkure, Sasko, Spekko, White Star, Smith's, Sting, SodaStream, Lubimy Sad, Pepsi, and other brands. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is based in Purchase, New York.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 3% and 8.7%, respectively.
More news about Pepsico.
20. Exact Sciences (EXAS)
Shares of Exact Sciences jumped by a staggering 14.64% in from $64.68 to $74.15 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Sales Growth
Exact Sciences’s sales growth is 14.2% for the present quarter and 10.6% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Exact Sciences’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 2.41B for the twelve trailing months.
More news about Exact Sciences.
21. Monolithic Power Systems (MPWR)
Shares of Monolithic Power Systems jumped by a staggering 14.74% in from $545.85 to $626.31 at 18:21 EST on Friday, after two sequential sessions in a row of losses. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Monolithic Power Systems, Inc. engages in the design, development, marketing, and sale of semiconductor-based power electronics solutions for the computing and storage, automotive, industrial, communications, and consumer markets. The company provides direct current (DC) to DC integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers and notebooks, monitors, infotainment applications, and medical equipment. It also offers lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in notebook computers, monitors, car navigation systems, and televisions, as well as for general illumination products. The company sells its products through third-party distributors and value-added resellers, as well as directly to original equipment manufacturers, original design manufacturers, electronic manufacturing service providers, and other end customers in China, Taiwan, Europe, South Korea, Southeast Asia, Japan, the United States, and internationally. Monolithic Power Systems, Inc. was incorporated in 1997 and is based in Kirkland, Washington.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.1%, now sitting on 1.83B for the twelve trailing months.
Moving Average
Monolithic Power Systems’s value is way above its 50-day moving average of $522.52 and way above its 200-day moving average of $499.52.
Sales Growth
Monolithic Power Systems’s sales growth is negative 1.5% for the present quarter and negative 4% for the next.
More news about Monolithic Power Systems.
22. Cognizant Technology Solutions (CTSH)
Shares of Cognizant Technology Solutions jumped 7.55% in from $69.89 to $75.17 at 18:21 EST on Friday, after five sequential sessions in a row of gains. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Health Sciences; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, automakers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to communications, media and entertainment, education, and information services and technology companies. The company has a strategic partnership with ServiceNow, Inc. to accelerate adoption of AI-driven automation across industries. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.
Volatility
Cognizant Technology Solutions’s last week, last month’s, and last quarter’s current intraday variation average was 0.30%, 0.40%, and 0.95%.
Cognizant Technology Solutions’s highest amplitude of average volatility was 0.30% (last week), 0.87% (last month), and 0.95% (last quarter).
More news about Cognizant Technology Solutions.
23. Amgen (AMGN)
Shares of Amgen jumped 6.96% in from $268.39 to $287.07 at 18:21 EST on Friday, after two consecutive sessions in a row of gains. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Amgen’s stock is considered to be oversold (<=20).
Moving Average
Amgen’s value is above its 50-day moving average of $271.64 and way above its 200-day moving average of $249.43.
Volatility
Amgen’s last week, last month’s, and last quarter’s current intraday variation average was 0.42%, 0.38%, and 1.12%.
Amgen’s highest amplitude of average volatility was 0.51% (last week), 0.96% (last month), and 1.12% (last quarter).
Yearly Top and Bottom Value
Amgen’s stock is valued at $287.07 at 18:21 EST, under its 52-week high of $288.46 and way above its 52-week low of $211.71.
More news about Amgen.
24. Adobe (ADBE)
Shares of Adobe dropped 2.68% in from $610.37 to $594.01 at 18:21 EST on Friday, after four consecutive sessions in a row of losses. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide. It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to create, publish, and promote content; and Document Cloud, a unified cloud-based document services platform. Its flagship product is Creative Cloud, a subscription service that allows members to access its creative products. This segment serves content creators, students, workers, marketers, educators, enthusiasts, communicators, and consumers. The Digital Experience segment provides an integrated platform and set of applications and services that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce. This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite. The Publishing and Advertising segment offers products and services, such as e-learning solutions, technical document publishing, web conferencing, document and forms platform, web application development, and high-end printing, as well as Advertising Cloud offerings. The company offers its products and services directly to enterprise customers through its sales force and local field offices, as well as to end users through app stores and through its website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, software vendors and developers, retailers, and original equipment manufacturers. The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018. Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.
Volatility
Adobe’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.23%, a negative 0.19%, and a positive 1.39%.
Adobe’s highest amplitude of average volatility was 0.23% (last week), 1.31% (last month), and 1.39% (last quarter).
Yearly Top and Bottom Value
Adobe’s stock is valued at $594.01 at 18:21 EST, under its 52-week high of $633.89 and way above its 52-week low of $318.60.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 19.41B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 15.3% and 12%, respectively.
More news about Adobe.
25. Wix.com (WIX)
Shares of Wix.com jumped by a staggering 21.78% in from $101.21 to $123.25 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Wix.com Ltd., together with its subsidiaries, develops and markets a cloud-based platform that enables to create a website or web application in North America, Europe, Latin America, Asia, and internationally. The company offers Wix Editor, a drag-and-drop visual development and website editing environment platform; Wix ADI that enables users to create a website for their specific needs. It also provides Wix Logo Maker that allows users to generate a logo using artificial intelligence; Wix Answers, a support infrastructure enabling its users to help their users across various channels; and Wix Payments, a payment platform, which helps its users receive payments from their users through their Wix Website. In addition, the company offers various vertical-specific applications that business owners use to operate various aspects of their business online. Further, it provides a range of complementary services, including App Market that offers its registered users the ability to install and uninstall a range of free and paid web applications; Wix marketplace that brings users seeking help in creating and managing a website, together with Web experts; and Wix owner App, a native mobile application, which enables users to manage their Websites and Wix operating systems. The company was formerly known as Wixpress Ltd. and changed its name to Wix.com Ltd. The company was incorporated in 2006 and is headquartered in Tel Aviv, Israel.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.51B for the twelve trailing months.
Moving Average
Wix.com’s worth is way higher than its 50-day moving average of $95.79 and way higher than its 200-day moving average of $88.91.
Sales Growth
Wix.com’s sales growth for the current quarter is 13.2%.
More news about Wix.com.
26. Microsoft (MSFT)
Shares of Microsoft dropped 0.62% in from $376.7 to $374.36 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 218.31B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 19.8% and 8.2%, respectively.
Yearly Top and Bottom Value
Microsoft’s stock is valued at $374.36 at 18:21 EST, under its 52-week high of $384.30 and way higher than its 52-week low of $219.35.
Previous days news about Microsoft
- Microsoft (msft), openai face charges from the New York times. According to Zacks on Thursday, 28 December, "The lawsuit, in this case, does not specify a monetary claim but suggests that OpenAI and Microsoft should be held responsible for substantial damages. ", "Additionally, Microsoft Azure provides the Azure OpenAI Service, facilitating the seamless application of LLMs and generative AI techniques across various applications."
More news about Microsoft.
27. Freshpet (FRPT)
Shares of Freshpet jumped by a staggering 23.61% in from $70.21 to $86.79 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
Freshpet, Inc. manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. Freshpet, Inc. was incorporated in 2004 and is headquartered in Secaucus, New Jersey.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Freshpet’s stock is considered to be oversold (<=20).
Volatility
Freshpet’s last week, last month’s, and last quarter’s current intraday variation average was 1.40%, 1.27%, and 1.76%.
Freshpet’s highest amplitude of average volatility was 1.40% (last week), 1.60% (last month), and 1.76% (last quarter).
More news about Freshpet.
28. IDEXX Laboratories (IDXX)
Shares of IDEXX Laboratories jumped by a staggering 19.95% in from $461.96 to $554.12 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is falling 0.56% to $15,011.35, following the last session’s downward trend.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
More news about IDEXX Laboratories.
29. Gilead Sciences (GILD)
Shares of Gilead Sciences rose 6% in from $76.32 to $80.90 at 18:21 EST on Friday, after five sequential sessions in a row of gains. NASDAQ is sliding 0.56% to $15,011.35, following the last session’s downward trend.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 27.39B for the twelve trailing months.
More news about Gilead Sciences.
30. American Airlines (AAL)
Shares of American Airlines rose by a staggering 10.91% in from $12.37 to $13.72 at 18:21 EST on Friday, after four consecutive sessions in a row of losses. NASDAQ is dropping 0.56% to $15,011.35, following the last session’s downward trend.
American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. As of December 31, 2022, it operated a mainline fleet of 925 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.
Previous days news about American Airlines
- American Airlines (aal) stock sinks as market gains: here's why. According to Zacks on Wednesday, 27 December, "Looking at its valuation, American Airlines is holding a Forward P/E ratio of 5.86. ", "The investment community will be closely monitoring the performance of American Airlines in its forthcoming earnings report. "
More news about American Airlines.
